老年2型糖尿病患者糖尿病护理的挑战及基础胰岛素的作用
Challenges of Diabetes Care in Older People With Type 2 Diabetes and the Role of Basal Insulin.
作者信息
Cersosimo Eugenio, Lee Pearl G, Pandya Naushira
机构信息
Texas Diabetes Institute, University Health System and the University of Texas Health Science Center at San Antonio, San Antonio, TX.
Division of Geriatric and Palliative Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, MI.
出版信息
Clin Diabetes. 2019 Oct;37(4):357-367. doi: 10.2337/cd18-0074.
Abstract
The use of long-acting basal insulin analogs is a recommended strategy in older people with diabetes because of their lower risk of hypoglycemia compared to intermediate-acting insulins. In this article, we review the results from recent clinical trials of second-generation basal insulin preparations. We conclude that, although these preparations have improved the management of insulin-requiring older people with type 2 diabetes, there is a need for additional and more specific studies to address the complexities of hyperglycemia management in this population.
摘要
由于与中效胰岛素相比，长效基础胰岛素类似物导致低血糖的风险较低，因此在老年糖尿病患者中使用长效基础胰岛素类似物是一种推荐的策略。在本文中，我们回顾了第二代基础胰岛素制剂近期临床试验的结果。我们得出结论，尽管这些制剂改善了需要胰岛素治疗的老年2型糖尿病患者的管理，但仍需要进行更多专门研究，以解决该人群高血糖管理的复杂性问题。
相似文献
1
Challenges of Diabetes Care in Older People With Type 2 Diabetes and the Role of Basal Insulin.
Clin Diabetes. 2019 Oct;37(4):357-367. doi: 10.2337/cd18-0074.
2
The role of the new basal insulin analogs in addressing unmet clinical needs in people with type 1 and type 2 diabetes.
Curr Med Res Opin. 2017 Jun;33(6):1045-1055. doi: 10.1080/03007995.2017.1298522. Epub 2017 Mar 24.
3
Addressing hyperglycemia from hospital admission to discharge.
Curr Med Res Opin. 2010 Mar;26(3):589-98. doi: 10.1185/03007990903566822.
4
Current usage of long-acting insulin analogs in patients with type 2 diabetes mellitus.
Expert Rev Endocrinol Metab. 2024 Mar;19(2):155-161. doi: 10.1080/17446651.2024.2320631. Epub 2024 Feb 20.
5
Efficacy and safety of the second generation basal insulin analogs in type 2 diabetes mellitus: A critical appraisal.
Diabetes Metab Syndr. 2019 May-Jun;13(3):2126-2141. doi: 10.1016/j.dsx.2019.05.001. Epub 2019 May 12.
6
Clinical perspectives on the frequency of hypoglycemia in treat-to-target randomized controlled trials comparing basal insulin analogs in type 2 diabetes: a narrative review.
BMJ Open Diabetes Res Care. 2024 May 14;12(3):e003930. doi: 10.1136/bmjdrc-2023-003930.
7
Biosynthetic Human Insulin and Insulin Analogs.
Am J Ther. 2020 Jan/Feb;27(1):e42-e51. doi: 10.1097/MJT.0000000000001089.
8
Understanding how pharmacokinetic and pharmacodynamic differences of basal analog insulins influence clinical practice.
Curr Med Res Opin. 2017 Oct;33(10):1821-1831. doi: 10.1080/03007995.2017.1335192. Epub 2017 Jun 23.
9
Continuous Subcutaneous Insulin Infusion (CSII) Pumps for Type 1 and Type 2 Adult Diabetic Populations: An Evidence-Based Analysis.
Ont Health Technol Assess Ser. 2009;9(20):1-58. Epub 2009 Oct 1.
10
Considerations for Insulin-Treated Type 2 Diabetes Patients During Hospitalization: A Narrative Review of What We Need to Know in the Age of Second-Generation Basal Insulin Analogs.
Diabetes Ther. 2020 Dec;11(12):2775-2790. doi: 10.1007/s13300-020-00920-z. Epub 2020 Sep 30.
引用本文的文献
1
Hypoglycaemia in Older Adults with Diabetes: Pathophysiology, Prevention, and Personalized Care in an Aging Population.
Drugs Aging. 2025 Sep 10. doi: 10.1007/s40266-025-01236-y.
2
Healthcare utilization and costs in adults with type 2 diabetes treated with first or second-generation basal insulins in England.
BMJ Open Diabetes Res Care. 2025 May 28;13(3):e005027. doi: 10.1136/bmjdrc-2025-005027.
3
A qualitative study of the experiences of insulin use by older people with type 2 diabetes mellitus.
BMC Prim Care. 2024 May 22;25(1):180. doi: 10.1186/s12875-024-02318-3.
4
DIVE/DPV registries: benefits and risks of analog insulin use in individuals 75 years and older with type 2 diabetes mellitus.
BMJ Open Diabetes Res Care. 2021 Jun;9(1). doi: 10.1136/bmjdrc-2021-002215.
5
Challenges and Strategies for Managing Diabetes in the Elderly in Long-Term Care Settings.
Diabetes Spectr. 2020 Aug;33(3):236-245. doi: 10.2337/ds20-0018.
本文引用的文献
1
A Randomized Controlled Trial Comparing Efficacy and Safety of Insulin Glargine 300 Units/mL Versus 100 Units/mL in Older People With Type 2 Diabetes: Results From the SENIOR Study.
Diabetes Care. 2018 Aug;41(8):1672-1680. doi: 10.2337/dc18-0168. Epub 2018 Jun 12.
2
1. Improving Care and Promoting Health in Populations: .
Diabetes Care. 2018 Jan;41(Suppl 1):S7-S12. doi: 10.2337/dc18-S001.
3
International Consensus on Use of Continuous Glucose Monitoring.
Diabetes Care. 2017 Dec;40(12):1631-1640. doi: 10.2337/dc17-1600.
4
INSULIN GLARGINE 300 U/ML IS ASSOCIATED WITH LESS WEIGHT GAIN WHILE MAINTAINING GLYCEMIC CONTROL AND LOW RISK OF HYPOGLYCEMIA COMPARED WITH INSULIN GLARGINE 100 U/ML IN AN AGING POPULATION WITH TYPE 2 DIABETES.
Endocr Pract. 2018 Feb;24(2):143-149. doi: 10.4158/EP171922.OR. Epub 2017 Nov 6.
5
Insulin glargine 300 U/mL for basal insulin therapy in type 1 and type 2 diabetes mellitus.
Diabetes Metab Syndr Obes. 2017 Jun 30;10:273-284. doi: 10.2147/DMSO.S131358. eCollection 2017.
6
Effects of age, gender, and body mass index on efficacy and hypoglycaemia outcomes across treat-to-target trials with insulin glargine 100 U/mL added to oral antidiabetes agents in type 2 diabetes.
Diabetes Obes Metab. 2017 Nov;19(11):1546-1554. doi: 10.1111/dom.12966. Epub 2017 Jul 27.
7
Insulin analogues in type 1 diabetes mellitus: getting better all the time.
Nat Rev Endocrinol. 2017 Jul;13(7):385-399. doi: 10.1038/nrendo.2017.39. Epub 2017 Apr 21.
8
Liberating A1C goals in older adults may not protect against the risk of hypoglycemia.
J Diabetes Complications. 2017 Jul;31(7):1197-1199. doi: 10.1016/j.jdiacomp.2017.02.014. Epub 2017 Mar 14.
9
The Pathophysiology of Hyperglycemia in Older Adults: Clinical Considerations.
Diabetes Care. 2017 Apr;40(4):444-452. doi: 10.2337/dc16-1732.
10
Efficacy and safety of thrice-weekly insulin degludec in elderly patients with type 2 diabetes assessed by continuous glucose monitoring.
Endocr J. 2016 Dec 30;63(12):1099-1106. doi: 10.1507/endocrj.EJ16-0252. Epub 2016 Sep 2.
Zotero 插件